In the same tumor type, in the presence of oncogenic activated EGFR and KRAS/ERK1/2, EGF promotes the secretion of IL-10 that increases the number of infiltrating Treg cells and M2-polarized TAMs [146]. The gene discussed is MAPK3; the disease is neoplasm.